LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK plc ("GSK" or "the Company") (NYSE: GSK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 5, 2020 and August 14, 2022, inclusive (the "Class Period"), are encouraged to contact the firm before April 7, 2025.

image for news GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit with the Schall Law Firm

XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM). After the mainland of China, South Korea, Australia and Singapore, Taiwan market is the fifth APAC market in which XPOVIO® has been approved for public health insurance coverage.

image for news Antengene Announces XPOVIO® Approved for Public Health Insurance Coverage in Taiwan Market, Benefiting More Patients with R/R MM in the Region

GLP-1 Drugs Drive Growth for Eli Lilly. Is the Stock a Buy? — Positive

LLY   The Motley Fool — February 13, 2025

After pre-announcing that its full-year revenue would come in below its original guidance, Eli Lilly (LLY 0.92%) announced its full results and reiterated its earlier 2025 forecast. The company has been a big beneficiary of GLP-1 drugs that have seen soaring demand as they have been shown to greatly help with multiple health issues, including weight control.

image for news GLP-1 Drugs Drive Growth for Eli Lilly. Is the Stock a Buy?

LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Intellia Therapeutics, Inc. ("Intellia" or "the Company") (NASDAQ: NTLA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 30, 2024 and January 8, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 14, 2025.

image for news NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Neumora Therapeutics, Inc. ("Neumora" or "the Company") (NASDAQ: NMRA) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents in connection with its initial public offering ("IPO") conducted on September 15, 2023, are encouraged to contact the firm before April 7, 2025.

image for news NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edison International ("Edison" or "the Company") (NYSE: EIX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 25, 2021 and February 6, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 14, 2025.

image for news EIX Investors Have Opportunity to Lead Edison International Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company ("Icon" or "the Company") (NASDAQ: ICLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 27, 2023 and October 23, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before April 11, 2025.

image for news ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm

Altria's Problems Go Deeper Than Just Falling Tobacco Sales — Negative

MO   The Motley Fool — February 13, 2025

Smoking rates have been declining significantly for decades. According to the American Lung Association, less than 12% of adults smoked in 2022, compared to nearly 43% in 1965.

image for news Altria's Problems Go Deeper Than Just Falling Tobacco Sales

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Harmonic Inc. ("Harmonic Inc.") (NASDAQ:HLIT) concerning possible violations of federal securities laws. Harmonic reported its third quarter financial results on February 10, 2025.

image for news Investors who lost money on Harmonic Inc. should contact Levi & Korsinsky about an ongoing investigation - HLIT

The German antitrust authority has notified Apple of concerns regarding the iPhone maker's app tracking tool, which could violate rules for large tech companies, the regulator said in a statement on Thursday.

image for news German cartel office warns Apple app tracking tool could violate rules

Meet the Glorious Growth Stock Billionaire Bill Ackman Is Buying Hand Over Fist — Positive

UBER   The Motley Fool — February 13, 2025

Bill Ackman is the founder and CEO of Pershing Square, a hedge fund with around $12.9 billion in assets under management. That includes billions of dollars invested in popular stocks like Alphabet, Nike, and Chipotle Mexican Grill.

image for news Meet the Glorious Growth Stock Billionaire Bill Ackman Is Buying Hand Over Fist

LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Olin Corporation ("Olin" or "the Company") (NYSE: OLN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

image for news OLN Investors Have Opportunity to Join Olin Corporation Fraud Investigation with the Schall Law Firm

Best Income Stocks to Buy for February 13th — Positive

FISI  SSB  SYF   Zacks Investment Research — February 13, 2025

FISI, SSB and SYF made it to the Zacks Rank #1 (Strong Buy) income stocks list on February 13, 2025.

image for news Best Income Stocks to Buy for February 13th

LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Oscar Health, Inc. ("Oscar Health" or "the Company") (NYSE: OSCR) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors.

image for news Oscar Health, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - OSCR

LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of STAAR Surgical Company ("Staar" or "the Company") (NASDAQ: STAA) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

image for news STAA Investors Have Opportunity to Join STAAR Surgical Company Fraud Investigation with the Schall Law Firm

LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of JinkoSolar Holding Co., Ltd. ("JinkoSolar" or "the Company") (NYSE: JKS) for violations of the securities laws.

image for news JKS Investors Have Opportunity to Join JinkoSolar Holding Co., Ltd. Fraud Investigation with the Schall Law Firm

Is Arm Holdings Stock a Buy Now? — Positive

ARM   The Motley Fool — February 13, 2025

Expectations were high for Arm Holdings (ARM -1.48%) going into its fiscal 2025 third-quarter report (for the three months ended Dec. 31, 2024). Shares of the British company shot up remarkably in the past year and are trading at a premium valuation, so it wasn't surprising to see the stock fall when its outlook barely matched Wall Street's expectations.

image for news Is Arm Holdings Stock a Buy Now?

The Twilio stock price has surged in the past few months, thanks to its growth trajectory and strong business performance. The TWLO share price jumped to $150 on Wednesday, the highest level since April 2022 and 258% from its lowest level in 2023.

image for news Twilio stock price forecast: technicals point to a surge after earnings

Google DeepMind scientist raises $50m for AI biotech start-up — Positive

GOOG  GOOGL   Proactive Investors — February 13, 2025

Latent Labs, a biotech startup founded by former DeepMind scientist Simon Kohl, has launched with $50 million in funding. The company is developing artificial intelligence models to design and optimise proteins, essential molecules in human biology.

image for news Google DeepMind scientist raises $50m for AI biotech start-up

Equinor to appeal $4 mln fine from French energy regulator — Negative

EQNR   Reuters — February 13, 2025

Norway's Equinor said on Thursday that the French energy regulator had imposed a fine of 4 million euros ($4.17 million) for violation of market regulations in France, and that it would appeal the fine.

image for news Equinor to appeal $4 mln fine from French energy regulator